PMB sees highest quarter for cross-border buyout value
A total of US$31.3 billion in cross-border PE buyout activity took place globally in the pharma, medical and biotech sector in the second quarter of 2022. This is the highest quarter on Mergermarket record (since 2006), overtaking the US$21.7 which occurred in the third quarter of 2021, the previous record high.